FDA commissioner talks push to loosen testosterone restrictions : NPR
Food and Drug Administration Commissioner Martin Makary speaks in the Oval Office of the White House during an event with President Trump Thursday, Oct. 16, in Washington.
Alex Brandon/AP
hide caption
toggle caption
Alex Brandon/AP
A panel of health experts from the Food and Drug Administration met Wednesday to discuss and promote the benefits of testosterone treatments for men’s health.
FDA Commissioner Martin Makary said Morning edition Low testosterone is thought to be associated with symptoms in about a third of men who suffer from it, although he said the evidence and data are not fully defined. Symptoms can include “reduced mood and vitality,” Makary said.
Speaking to NPR’s Steve Inskeep, Makary explained why the FDA wants to reconsider medical access to testosterone and the stigma associated with its use.
Listen to the full conversation by clicking the blue play button above.
The radio version of this story was edited by Adam Bearne and produced by Lilly Quiroz. Web copy was written by Obed Manuel and edited by Majd Al-Waheidi.
